Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis
- 1 February 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 99 (2) , 251-255
- https://doi.org/10.1530/acta.0.0990251
Abstract
A 9 yr old Mexican boy presented with severe hypertension, hypokalemia and features suggesting acute glomerulonephritis. Nephrosclerosis was present on renal biopsy. Aldosterone levels were unresponsive to variations in dietary salt intake and plasma renin activity was suppressed. Following oral dexamethasone therapy (2 mg/day), plasma aldosterone decreased to undetectable levels, serum K normalized and plasma renin activity gradually increased. Dexamethasone also restored the normal responsiveness of the renin-aldosterone system to postural stimuli. The patient exhibited a marked response to a single dose of ACTH with a rise in plasma aldosterone. Long-term blood pressure control and normal K levels have been achieved with oral prednisone therapy (5 mg/day) for a period of 1 yr. This case of dexamethasone suppressible hyperaldosteronism (DSH) illustrates that the degree of hypertension in this syndrome may produce severe renal microvascular lesions. DSH should be considered in all children who present with low renin hypertension.This publication has 3 references indexed in Scilit:
- Familial, Dexamethasone-Suppressible, Normokalemic HyperaldosteronismPediatrics, 1980
- Evidence for an Unidentified ACTH-Induced Steroid Hormone Causing HypertensionJournal of Clinical Endocrinology & Metabolism, 1976
- Aldosterone excretion in normal children and in children with adrenal hyperplasia.Journal of Clinical Investigation, 1966